These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8886855

  • 1. Thymosin alpha 1 interacts with the VIP receptor-effector system in rat and mouse immunocompetent cells.
    Pozo D, Guerrero JM, Segura JJ, Calvo JR.
    Immunopharmacology; 1996 Sep; 34(2-3):113-23. PubMed ID: 8886855
    [Abstract] [Full Text] [Related]

  • 2. Interaction of thymic peptide thymosin alpha 1 with VIP receptors in rat intestinal epithelial cells: comparison with PHI and secretin.
    Calvo JR, Guerrero JM, Goberna R.
    Gen Pharmacol; 1989 Sep; 20(4):503-5. PubMed ID: 2546855
    [Abstract] [Full Text] [Related]

  • 3. Interaction of thymic peptide thymosin alpha 1 with vasoactive intestinal peptide (VIP) receptors.
    Calvo JR, Goberna R, Guerrero JM.
    Biosci Rep; 1986 Aug; 6(8):727-33. PubMed ID: 3028522
    [Abstract] [Full Text] [Related]

  • 4. Homologous regulation of vasoactive intestinal peptide (VIP) receptors on rat peritoneal macrophages.
    Pozo D, Guerrero JM, Calvo JR.
    Peptides; 1995 Aug; 16(2):313-8. PubMed ID: 7784261
    [Abstract] [Full Text] [Related]

  • 5. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 6. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages.
    Pozo D, Montilla ML, Guerrero JM, Calvo JR.
    Eur J Pharmacol; 1997 Mar 05; 321(3):379-86. PubMed ID: 9085051
    [Abstract] [Full Text] [Related]

  • 7. Expression of VIP receptors in mouse peritoneal macrophages: functional and molecular characterization.
    Calvo JR, Montilla ML, Guerrero JM, Segura JJ.
    J Neuroimmunol; 1994 Feb 05; 50(1):85-93. PubMed ID: 8300860
    [Abstract] [Full Text] [Related]

  • 8. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
    Sakakibara H, Shima K, Said SI.
    Am J Physiol; 1994 Sep 05; 267(3 Pt 1):L256-62. PubMed ID: 7943252
    [Abstract] [Full Text] [Related]

  • 9. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P, Coy DH, De Neef P, Camus JC, Cauvin A, Waelbroeck M, Christophe J.
    Eur J Biochem; 1987 Jun 01; 165(2):243-9. PubMed ID: 3036504
    [Abstract] [Full Text] [Related]

  • 10. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
    Gourlet P, Vandermeers A, Van Rampelbergh J, De Neef P, Cnudde J, Waelbroeck M, Robberecht P.
    Ann N Y Acad Sci; 1998 Dec 11; 865():247-52. PubMed ID: 9928018
    [Abstract] [Full Text] [Related]

  • 11. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC, Gardner JD, Jensen RT.
    Am J Physiol; 1989 Feb 11; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [Abstract] [Full Text] [Related]

  • 12. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
    Lundberg P, Lundgren I, Mukohyama H, Lehenkari PP, Horton MA, Lerner UH.
    Endocrinology; 2001 Jan 11; 142(1):339-47. PubMed ID: 11145597
    [Abstract] [Full Text] [Related]

  • 13. Characterization of VIP-and helodermin-preferring receptors on rat platelets.
    Shima K, Sakakibara H, Said SI.
    Regul Pept; 1996 Jul 05; 63(2-3):99-103. PubMed ID: 8837217
    [Abstract] [Full Text] [Related]

  • 14. Interaction of a bovine thymic peptide extract with vasoactive intestinal peptide (VIP) receptors.
    Guerrero JM, Goberna R, Molinero P, Jimenez J, Calvo JR.
    Biosci Rep; 1986 Jun 05; 6(6):579-84. PubMed ID: 3021253
    [Abstract] [Full Text] [Related]

  • 15. Characterization of vasoactive intestinal peptide receptors in human liver.
    Rodríguez-Henche N, Rodríguez-Pena MS, Guijarro LG, Prieto JC.
    Biochim Biophys Acta; 1994 Mar 31; 1221(2):193-8. PubMed ID: 8148398
    [Abstract] [Full Text] [Related]

  • 16. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ.
    J Mol Neurosci; 2005 Mar 31; 25(3):215-24. PubMed ID: 15800375
    [Abstract] [Full Text] [Related]

  • 17. Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology.
    Gespach C, Bataille D, Vauclin N, Moroder L, Wünsch E, Rosselin G.
    Peptides; 1986 Mar 31; 7 Suppl 1():155-63. PubMed ID: 3018694
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of receptors for VIP in rat peritoneal macrophage membranes.
    Calvo JR, Guerrero JM, López-Gonzalez MA, Osuna C, Segura JJ.
    Peptides; 1994 Mar 31; 15(2):309-15. PubMed ID: 8008637
    [Abstract] [Full Text] [Related]

  • 19. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages.
    Segura JJ, Guerrero JM, Goberna R, Calvo JR.
    Regul Pept; 1991 Apr 25; 33(2):133-43. PubMed ID: 1652777
    [Abstract] [Full Text] [Related]

  • 20. Characterization of adenylyl cyclase stimulated by VIP in rat and mouse peritoneal macrophage membranes.
    Pozo D, Segura JJ, Carrero I, Guijarro LG, Prieto JC, Calvo JR.
    Biochim Biophys Acta; 1996 Jul 24; 1312(3):249-54. PubMed ID: 8703995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.